These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18722915)

  • 21. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated limb perfusion for malignant melanoma; possibly better results with high dose hyperthermia.
    Van der Zee J; Kroon BB
    Int J Hyperthermia; 2008 Nov; 24(7):602-3; author reply 604. PubMed ID: 18979311
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
    Brady MS; Brown K; Patel A; Fisher C; Marx W
    Melanoma Res; 2009 Apr; 19(2):106-11. PubMed ID: 19282789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.
    Taeger G; Grabellus F; Podleska LE; Müller S; Ruchholtz S
    Int J Hyperthermia; 2008 May; 24(3):193-203. PubMed ID: 18392998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation limb perfusion for melanoma: current trends and future directions.
    Coit DG
    Melanoma Res; 1994 Mar; 4 Suppl 1():57-60. PubMed ID: 8038599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma.
    Duprat JP; Domingues AL; Coelho EG; Leal RM; Nishinari K; Neves RI
    Eur J Surg Oncol; 2009 Jun; 35(6):568-72. PubMed ID: 19013049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The European approach to in-transit melanoma lesions.
    Hoekstra HJ
    Int J Hyperthermia; 2008 May; 24(3):227-37. PubMed ID: 18393001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extremity perfusion for sarcoma.
    Hoekstra HJ
    Surg Oncol Clin N Am; 2008 Oct; 17(4):805-24, ix. PubMed ID: 18722920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The past decade of experience with isolated hepatic perfusion.
    Grover A; Alexander HR
    Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of hyperthermia in optimizing tumor response to regional therapy.
    Moyer HR; Delman KA
    Int J Hyperthermia; 2008 May; 24(3):251-61. PubMed ID: 18393003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory models of regional chemotherapy.
    Ten Hagen TL; Eggermont AM
    Int J Hyperthermia; 2008 May; 24(3):291-9. PubMed ID: 18393006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity.
    Ko SH; Ueno T; Yoshimoto Y; Yoo JS; Abdel-Wahab OI; Abdel-Wahab Z; Chu E; Pruitt SK; Friedman HS; Dewhirst MW; Tyler DS
    Clin Cancer Res; 2006 Jan; 12(1):289-97. PubMed ID: 16397054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid HPLC analysis of melphalan applied to hyperthermic isolation limb perfusion.
    Romanová D; Netriová J; Bozek P; Ovesná Z; Kroupa K; Valovicová E; Vachálková A
    Neoplasma; 2003; 50(2):120-4. PubMed ID: 12740646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T-cell lymphoma.
    Elhassadi E; Egan E; O'sullivan G; Mohamed R
    Clin Lab Haematol; 2006 Aug; 28(4):279-81. PubMed ID: 16898971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loco-regional perfusions (stop-flow techniques): state of art and future.
    Guadagni S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):119-22. PubMed ID: 16767917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings.
    Miotto D; Miotto D; Bertolo S; Minante M; Darisi T; Mocellin S; Casara D; Ori C; Foletto M; Rossi CR; Lise M; Nitti D
    J Chemother; 2004 Nov; 16 Suppl 5():44-7. PubMed ID: 15675477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of regional chemotherapy for cancer of the extremities.
    Ariyan CE; Brady MS
    Int J Hyperthermia; 2008 May; 24(3):185-92. PubMed ID: 18392997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Merkel cell carcinoma: an unusual indication for isolated limb perfusion.
    Ponte P; Moniz JV; Farricha V; Weinholtz JB
    Dermatol Online J; 2008 Jul; 14(7):6. PubMed ID: 18718190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.